RDIF names countries where they plan to produce Sputnik V

“We confirm that we can supply large volumes in December this year.

We will produce in India, Brazil, Korea, China and in one more country, ”Dmitrieva quotes TASS.

Earlier it was reported that RDIF and the Indian pharmaceutical company Dr.

Reddy's has been approved by the Comptroller General of India (DCGI) to conduct Phase II and III clinical trials for Sputnik V vaccine in India.

Professor of the Department of Virology at the Belozersky Institute of Moscow State University, Alexei Agranovsky, in an interview with URA.RU, assessed the immunity of those vaccinated against COVID-19.